These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 9828547

  • 21. Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers.
    Leal C, Henrique R, Monteiro P, Lopes C, Bento MJ, De Sousa CP, Lopes P, Olson S, Silva MD, Page DL.
    Hum Pathol; 2001 May; 32(5):487-93. PubMed ID: 11381366
    [Abstract] [Full Text] [Related]

  • 22. Aspiration biopsy smear pattern as a predictor of biologic behavior in adenocarcinoma of the breast.
    Layfield LJ, Robert ME, Cramer H, Giuliano A.
    Acta Cytol; 1992 May; 36(2):208-14. PubMed ID: 1311888
    [Abstract] [Full Text] [Related]

  • 23. Relationship between AgNORs, MIB-1 and oncogene expression in male breast carcinoma and papillary superficial bladder neoplasm.
    Pich A, Margaria E, Chiusa L, Bortolin P, Palestro G.
    Oncol Rep; 2003 May; 10(5):1329-35. PubMed ID: 12883702
    [Abstract] [Full Text] [Related]

  • 24. Cytologic differential diagnosis of papillary pattern in breast aspirates: correlation with histology.
    Nayar R, De Frias DV, Bourtsos EP, Sutton V, Bedrossian C.
    Ann Diagn Pathol; 2001 Feb; 5(1):34-42. PubMed ID: 11172205
    [Abstract] [Full Text] [Related]

  • 25. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
    Tomobe M, Shimazui T, Uchida K, Hinotsu S, Akaza H.
    J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Breast carcinoma in women 35 years and younger: a pathological study.
    Fernandopulle SM, Cher-Siangang P, Tan PH.
    Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer.
    Logullo AF, Lopes AB, Nonogaki S, Soares FA, Netto MM, Nishimoto IN, Brentani MM.
    Oncol Rep; 2007 Jul; 18(1):121-6. PubMed ID: 17549356
    [Abstract] [Full Text] [Related]

  • 33. Evaluation of significance of AgNOR counts in differentiating benign from malignant lesions in the breast.
    Dube MK, Govil A.
    Indian J Pathol Microbiol; 1995 Jan; 38(1):5-10. PubMed ID: 8919463
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
    Gong Y, Booser DJ, Sneige N.
    Cancer; 2005 May 01; 103(9):1763-9. PubMed ID: 15786420
    [Abstract] [Full Text] [Related]

  • 38. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D, Juretić A, Sarcević B, Separović V, Kujundzić-Tiljak M, Hudolin T, Spagnoli GC, Cović D, Samija M.
    Croat Med J; 2006 Feb 01; 47(1):32-41. PubMed ID: 16489695
    [Abstract] [Full Text] [Related]

  • 39. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
    Tezel GG, Uner A, Yildiz I, Guler G, Takahashi M.
    Pathol Res Pract; 2009 Feb 01; 205(6):403-8. PubMed ID: 19232840
    [Abstract] [Full Text] [Related]

  • 40. Argyrophilic nucleolar organizer regions: their value and correlation with clinical prognostic factors in breast carcinoma.
    Kumar A, Kushwaha AK, Kumar M, Gupta S.
    J Surg Oncol; 1997 Jul 01; 65(3):201-4. PubMed ID: 9236930
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.